$4.56
0.020.44%
Last update: Nov 4, 4:00 PM

The average analyst price target for CytoSorbents is $96.90, 1707.8% above the current price. Of 4 analysts, 3 rate it Buy and 1 Hold. Targets range from $9.50 to $200. The latest change came on Oct 21, 2026, when WBB Securities initiated coverage of CytoSorbents with a Speculative Buy rating and a $9.50 price target.
Price Target Range — 11 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months